发明申请
- 专利标题: NEW INDICATION OF AZELNIDIPINE PHARMACEUTICAL COMPOSITION FOR TREATING CANCER
-
申请号: US15521500申请日: 2015-10-23
-
公开(公告)号: US20170312260A1公开(公告)日: 2017-11-02
- 发明人: Chiu-Hung Chen , Show-Mei Chuang , Tzong-Der Way , Nai-Wan Hsiao
- 申请人: LAUNX BIOMEDICAL CO., LTD.
- 申请人地址: TW Kaohsiung
- 专利权人: LAUNX BIOMEDICAL CO., LTD.
- 当前专利权人: LAUNX BIOMEDICAL CO., LTD.
- 当前专利权人地址: TW Kaohsiung
- 国际申请: PCT/CN2015/092714 WO 20151023
- 主分类号: A61K31/4427
- IPC分类号: A61K31/4427
摘要:
A method for treating a cancer includes administering to a subject in need thereof a pharmaceutical composition containing a therapeutically effective amount of Azelnidipine or a pharmaceutical acceptable salt thereof. The cancer is selected from the group consisting of a pleural-related cancer, an abdominal-related cancer, an endocrine-related cancer, a gastrointestinal tract-related cancer, osteosarcoma, and skin cancer.
信息查询
IPC分类: